Search

Our doctors and researchers are constantly seeking new and improved treatments for salivary gland cancer through our program of clinical trials.

… Doctors at Memorial Sloan Kettering are constantly working to improve treatment for salivary gland cancer through research studies called clinical trials. Participating in a clinical trial may give you access to treatments that are not widely available elsewhere. A clinical trial may offer you additional

After diagnosing MDS, MSK doctors will determine which subtype you have. Learn more.

… There are many subtypes of MDS. The subtype is determined using the results of blood and bone marrow tests. (Learn about these tests and how MDS is diagnosed.) MDS subtype is determined using either the World Health Organization (WHO) classification system or the French-American-British (FAB) classification

Our team of gastrointestinal surgeons, endocrinologists, pathologists, and medical oncologists provides comprehensive, personalized care for people with gastrointestinal neuroendocrine tumors.

… The gastrointestinal neuroendocrine tumor team at Memorial Sloan Kettering is a multidisciplinary group of doctors that includes surgeons, medical oncologists, radiation oncologists, endocrinologists, nuclear medicine specialists, interventional radiologists, radiologists, and pathologists. Our team

MSK experts in many areas work as a team to treat people with multiple myeloma and related plasma cell diseases.

… MSK experts in many areas work as a team to treat people with multiple myeloma and related plasma cell diseases. Your MSK care team will include experts in :   Hematologic oncology Stem cell transplants Radiation oncology Radiology Pathology Pain management   Request an Appointment Call 800-525-2225

A leader in prostate cancer diagnosis & treatment.

… Prostate cancer is the second most common cancer among men in the U.S., especially for those over age 50. Most prostate cancers are not a problem because they grow slowly. Many men get prostate cancer if they live a long life, but they die with prostate cancer, not from it. The prostate is a small gland

Líder en el diagnóstico y tratamiento del cáncer de próstata.

… El cáncer de próstata es el segundo tipo de cáncer más frecuente en hombres en los EE. UU., sobre todo en aquellos mayores de 50 años. La mayoría de los tipos de cáncer de próstata no son problemáticos, ya que se desarrollan lentamente. Muchos hombres enfermarán de cáncer de próstata si viven vidas largas

Learn how chemotherapy for bladder cancer can be used before or after surgery, or as the main treatment when surgery is not an option for advanced bladder cancer that has spread.

… MSK’s medical oncologists (cancer doctors) are experts in treating bladder cancer with chemotherapy . This treatment uses a drug or combination of drugs to kill cancer cells anywhere in your body. You may have chemotherapy before or after surgery.   Request an Appointment Call 800-525-2225 We’re available

Learn about and meet the liver cancer Memorial Sloan Kettering doctors, surgeons and other experts who have worked as a team to treat more than 5,000 people with liver cancer over the past decade and can put together a customized care plan for you from diagnosis through treatment.

… Memorial Sloan Kettering doctors, surgeons and other experts are among the most experienced in the world at diagnosing and treating primary liver cancer. Over the past decade, we have treated more than 5,000 people with liver cancer. Our group of nearly 30 specialists includes surgeons, medical oncologists

Learn about rare pediatric kidney cancers tumors that appear in children and how we treat them at MSK Kids.

… MSK Kids’ pediatric kidney tumor experts are exceptionally skilled at diagnosing and treating kidney cancers and tumors in children that doctors elsewhere may rarely, if ever, see. Our tools, treatments, and support services ensure that your child has the best chance of beating the disease. Rhabdoid

Hairy cell leukemia (HCL) is a rare cancer in adults that is usually found during testing for a low blood count. Read more about what doctors at MSK are looking for when they diagnose HCL.

… Hairy cell leukemia (HCL) is a rare chronic leukemia in adults. Around 1,000 people in the United States develop HCL each year, according to the World Health Organization. The average age at diagnosis is 52. HCL is more common in men than in women. There is no clear evidence that HCL runs in families